Immune checkpoint pathways regulate T cell function and play pivotal roles in the treatment of both cancer and autoimmune ...

CAMPATH-1, an antibody to human lymphocytes (antibody to CD52) now commercially available as alemtuzumab, emerged from that line of thinking 10.

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...

The Phase I trial is being conducted by the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands. In addition to ...

The FDA granted accelerated approval of linvoseltamab-gcpt for certain patients with multiple myeloma.Specifically, the ...

GSK’s approval expands belimumab treatment options, offering a first-of-its-kind subcutaneous option that can be administered ...

Hidden food sensitivities cause delayed immune reactions that escape allergy tests but trigger chronic inflammation and ...

Antibody specificity can be determined and HLA or HNA typing of the recipient's or donors' cells can also be carried out. The presence of a positive reverse lymphocyte crossmatch between donor ...

Immunotherapy is reshaping treatment for pemphigus and bullous pemphigoid with promising results from biologics like rituximab and dupilumab. Learn how precision immunology is advancing care.

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...